http://rdf.ncbi.nlm.nih.gov/pubchem/patent/MX-2014013839-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_966a6c1f382ec9bcb5e3839dfd73e5b8
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D417-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-00
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D417-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-541
filingDate 2013-05-21-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c353688bb10f62045de7fdb3c5617745
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_61b7fd4bbec84335debed33adb09590f
publicationDate 2015-02-04-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber MX-2014013839-A
titleOfInvention 5-AMINO [1,4] THIAZINS AS INHIBITORS OF BETA-SECRETASE 1 (BACE 1).
abstract The present invention relates to a compound of formula I having BACE1 inhibitory activity, its manufacture, pharmaceutical compositions containing it and its use as therapeutically active substances. The active compounds of the present invention are useful in the therapeutic and / or prophylactic treatment of, for example, Alzheimer's disease.
priorityDate 2012-05-24-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID23821
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID614333
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID431341128
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID23621
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID90024605
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID585631
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID29392

Total number of triples: 23.